[HTML][HTML] The role of RNA m5C modification in cancer metastasis
Q Zhang, F Liu, W Chen, H Miao, H Liang… - … journal of biological …, 2021 - ncbi.nlm.nih.gov
Epigenetic modification plays a crucial regulatory role in the biological processes of
eukaryotic cells. The recent characterization of DNA and RNA methylation is still ongoing …
eukaryotic cells. The recent characterization of DNA and RNA methylation is still ongoing …
[HTML][HTML] The biological function of m6A reader YTHDF2 and its role in human disease
J Wang, A Lu - Cancer cell international, 2021 - Springer
Abstract N6-methyladenosine (m6A) modification is a dynamic and reversible post-
transcriptional modification and the most prevalent internal RNA modification in eukaryotic …
transcriptional modification and the most prevalent internal RNA modification in eukaryotic …
Dynamic transcriptomic m5C and its regulatory role in RNA processing
YS Chen, WL Yang, YL Zhao… - Wiley Interdisciplinary …, 2021 - Wiley Online Library
Abstract RNA 5‐methylcytosine (m5C) is a prevalent RNA modification in multiple RNA
species, including messenger RNAs (mRNAs), transfer RNAs (tRNAs), ribosomal RNAs …
species, including messenger RNAs (mRNAs), transfer RNAs (tRNAs), ribosomal RNAs …
[HTML][HTML] Main N6-methyladenosine readers: YTH family proteins in cancers
XY Dai, L Shi, Z Li, HY Yang, JF Wei, Q Ding - Frontiers in Oncology, 2021 - frontiersin.org
Among the over 150 RNA modifications, N6-methyladenosine (m6A) is the most abundant
internal modification in eukaryotic RNAs, not only in messenger RNAs, but also in …
internal modification in eukaryotic RNAs, not only in messenger RNAs, but also in …
[HTML][HTML] Insight into the structure, physiological function, and role in cancer of m6A readers—YTH domain-containing proteins
J Liao, Y Wei, J Liang, J Wen, X Chen, B Zhang… - Cell death …, 2022 - nature.com
Abstract YT521-B homology (YTH) domain-containing proteins (YTHDF1-3, YTHDC1-2) are
the most crucial part of N6-methyladenosine (m6A) readers and play a regulatory role in …
the most crucial part of N6-methyladenosine (m6A) readers and play a regulatory role in …
[HTML][HTML] Functions of N6-methyladenosine and its role in cancer
L He, H Li, A Wu, Y Peng, G Shu, G Yin - Molecular cancer, 2019 - Springer
Abstract N6-methyladenosine (m6A) is methylation that occurs in the N6-position of
adenosine, which is the most prevalent internal modification on eukaryotic mRNA …
adenosine, which is the most prevalent internal modification on eukaryotic mRNA …
[HTML][HTML] 5-methylcytosine RNA methyltransferases and their potential roles in cancer
M Li, Z Tao, Y Zhao, L Li, J Zheng, Z Li… - Journal of translational …, 2022 - Springer
Abstract In recent years, 5-methylcytosine (m5C) RNA modification has emerged as a key
player in regulating RNA metabolism and function through coding as well as non-coding …
player in regulating RNA metabolism and function through coding as well as non-coding …
[HTML][HTML] The potential role of RNA N6-methyladenosine in Cancer progression
T Wang, S Kong, M Tao, S Ju - Molecular cancer, 2020 - Springer
Abstract N6-methyladenosine (m6A) is considered the most common, abundant, and
conserved internal transcript modification, especially in eukaryotic messenger RNA (mRNA) …
conserved internal transcript modification, especially in eukaryotic messenger RNA (mRNA) …
[HTML][HTML] YTH Domain Proteins: A Family of m6A Readers in Cancer Progression
Y Xu, W Zhang, F Shen, X Yang, H Liu, S Dai… - Frontiers in …, 2021 - frontiersin.org
N 6-methyladenosine (m 6 A) is the most abundant internal modification in eukaryotic
messenger RNAs (mRNAs). m6A RNA methylation is involved in all stages of RNA life cycle …
messenger RNAs (mRNAs). m6A RNA methylation is involved in all stages of RNA life cycle …
[HTML][HTML] Oncogene c-Myc promotes epitranscriptome m6A reader YTHDF1 expression in colorectal cancer
Recent studies that have emerged on the diversity of RNA modification in tumors suggest
their eligibility as bona fide targets in diagnosis and drug discovery. N6-methyladenosine (m …
their eligibility as bona fide targets in diagnosis and drug discovery. N6-methyladenosine (m …